The Denosumab market was valued at USD 2,892.17 Million in 2022 and is expected to reach USD 7,109.92 Million by 2030, growing at a CAGR of 11.9% (2023-2030). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.